metastatic renal cell carcinoma

Showing 1 - 25 of 131

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +255 more
Aug 24, 2022

Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Cyclophosphamide 50mg
  • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
  • Cambridge, United Kingdom
  • +3 more
Aug 22, 2022

Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

Recruiting
  • Metastatic Melanoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
  • Combination PD-1/PD-L1 ICI + VEGFR-TKI
  • Treatment pause
  • Bayonne, France
  • +24 more
Aug 10, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +48 more
Aug 10, 2022

Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood

Recruiting
  • Cardiovascular Disorder
  • +8 more
  • Best Practice
  • +4 more
  • Creve Coeur, Missouri
  • +24 more
Aug 10, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Aug 9, 2022

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +3 more
  • Avelumab
  • +7 more
  • Danville, Illinois
  • +4 more
Jul 29, 2022

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jun 28, 2022

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Metastatic Renal Cell Carcinoma Trial in France (PRISM care program)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • PRISM care program
  • Angers, France
  • +11 more
Apr 22, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute┬«-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Palo Alto (Doppler ultrasound, Long Ensemble Angular-coherence

Recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Doppler ultrasound
  • +2 more
  • Palo Alto, California
    Stanford
Mar 22, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Metastatic Renal Cell Carcinoma Trial in Australia, Canada (Ipilimumab/ Nivolumab, SBRT + Ipilimumab/Nivolumab)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab/ Nivolumab
  • SBRT + Ipilimumab/Nivolumab
  • Melbourne, Australia
  • +7 more
Mar 30, 2022

Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial in Duarte (Behavioral Intervention, Quality-of-Life

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Behavioral Intervention
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Angers, France
  • +8 more
Mar 16, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Advanced Solid Tumors, Metastatic Renal Cell Carcinoma Trial in United States (Part 1: M8891)

Terminated
  • Advanced Solid Tumors
  • Metastatic Renal Cell Carcinoma
  • Part 1: M8891
  • New Haven, Connecticut
  • +6 more
Dec 21, 2021

Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab plus nivolumab
  • Standard Therapy
  • Gent, Belgium
  • +40 more
Feb 7, 2022